SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-128828
Filing Date
2017-04-19
Accepted
2017-04-19 16:29:56
Documents
3
Period of Report
2017-04-15
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d361379d8k.htm 8-K 20136
2 EX-3.1 d361379dex31.htm EX-3.1 22679
3 EX-3.2 d361379dex32.htm EX-3.2 115597
  Complete submission text file 0001193125-17-128828.txt   159773
Mailing Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109
Business Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 17770319
SIC: 2834 Pharmaceutical Preparations